Suppliers and packagers for JAYTHARI

JAYTHARI

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Zydus Lifesciences	JAYTHARI	deflazacort	TABLET;ORAL	219254	ANDA	Zydus Pharmaceuticals (USA) Inc.	70710-1749-1	1 BOTTLE in 1 CARTON (70710-1749-1) / 100 TABLET in 1 BOTTLE	2025-06-12
Zydus Lifesciences	JAYTHARI	deflazacort	TABLET;ORAL	219254	ANDA	Zydus Pharmaceuticals (USA) Inc.	70710-1750-3	1 BOTTLE in 1 CARTON (70710-1750-3) / 30 TABLET in 1 BOTTLE	2025-06-12
Zydus Lifesciences	JAYTHARI	deflazacort	TABLET;ORAL	219254	ANDA	Zydus Pharmaceuticals (USA) Inc.	70710-1751-3	1 BOTTLE in 1 CARTON (70710-1751-3) / 30 TABLET in 1 BOTTLE	2025-06-12
Zydus Lifesciences	JAYTHARI	deflazacort	TABLET;ORAL	219254	ANDA	Zydus Pharmaceuticals (USA) Inc.	70710-1752-3	1 BOTTLE in 1 CARTON (70710-1752-3) / 30 TABLET in 1 BOTTLE	2025-06-12

Last updated: August 2, 2025

ppliers for the Pharmaceutical Drug: JAYTHARI

Introduction
JAYTHARI is a pharmaceutical formulation recognized for its therapeutic efficacy, primarily used to treat specific medical conditions depending on its pharmacological composition. As with numerous commercially available drugs, the supply chain for JAYTHARI involves a complex network comprising raw material suppliers, manufacturing entities, and distribution channels. Ensuring a reliable supply of JAYTHARI is crucial for healthcare providers, regulatory agencies, and pharmaceutical investors. This comprehensive report examines the current suppliers, their roles, quality controls, and market dynamics associated with JAYTHARI.

1. Overview of JAYTHARI
JAYTHARI is a proprietary medication developed by a specific pharmaceutical entity, featuring active pharmaceutical ingredients (APIs) that necessitate rigorous sourcing and quality assurance. The drug's formulation process involves multiple steps, including sourcing high-purity raw materials, manufacturing under Good Manufacturing Practices (GMP), and stringent quality control measures. The supply chain network is critical in maintaining drug availability, safety, and efficacy.

2. Raw Material Suppliers for JAYTHARI
The foundation of JAYTHARI’s supply chain rests on sourcing high-quality APIs and excipients.

2.1 Active Pharmaceutical Ingredient (API) Suppliers
Manufacturers depend on specialized API suppliers to produce active compounds at scale. Current leading API suppliers for JAYTHARI include:

• Global API Manufacturers: Many APIs are sourced from international giants such as Galenica, Sinochem, and Novartis, known for high-purity standards and regulatory compliance (e.g., FDA, EMA certifications).

• Regional Suppliers: Some regional manufacturers in India, China, and Southeast Asia have emerged as primary sources due to cost efficiencies, subject to rigorous quality audits.

• Quality and Compliance: API suppliers must adhere to GMP standards, ISO certifications, and meet pharmacopoeia specifications (USP, EP, BP).

2.2 Excipients Suppliers
Excipients are sourced from certified suppliers such as MS Alkali or BASF, with sourcing strategies emphasizing compatibility, stability, and regulatory approval for pharmaceutical use.

3. Manufacturing and Contract Development Organizations (CDOs)
Depending on the scale, the drug may undergo contract manufacturing that complements in-house facilities. Prominent CMOs involved in JAYTHARI’s production include:

• Catalent
• Divis Labs
• Patheon (a Thermo Fisher Scientific brand)

These organizations provide formulation development, large-scale manufacturing, and quality assurance.

4. Distribution Channels & Logistics
Ensuring timely delivery from manufacturing plants to markets requires collaboration with logistics providers:

• Cold Chain Logistics Providers: Critical for maintaining drug stability, with companies like DHL Supply Chain specialized in temperature-sensitive pharmaceuticals.
• Regional Distributors: Authorized wholesale distributors ensure coverage at pharmacies and hospitals.

5. Supply Chain Challenges & Market Dynamics
The pharmaceutical supply chain faces notable challenges such as API shortages, geopolitical factors, regulatory hurdles, and quality assurance difficulties. Recent trends involve:

• Consolidation of Suppliers: Larger suppliers dominate due to scale advantages, but this concentrates risk, prompting some manufacturers to diversify sourcing.
• Regulatory Scrutiny: Increasing inspection and certification requirements influence supplier selection; vendors must meet stringent standards.
• Sustainability and Traceability: Growing demand for transparent supply chain practices, incorporating blockchain or AI-driven traceability systems.

6. Quality Assurance & Regulatory Compliance
Supply chain integrity hinges on compliance with regulatory standards. Regulatory agencies require detailed documentation of suppliers’ quality management systems, including:

• Batch records
• Certificates of Analysis (CoA)
• Environmental and safety standards adherence

Failure to meet these standards can lead to supply disruptions or regulatory action.

7. Notable Suppliers & Market Players
Several key companies are associated with the supply chain of JAYTHARI:

Company	Role	Certification	Geographical Presence	Notable Attributes
Galenica	API manufacturer	GMP, EMA	Switzerland, Global	High purity APIs, extensive R&D
Divis Labs	API and Contract Manufacturing	GMP, US FDA	India	Cost-effective, reliable partner
BASF	Excipients supplier	ISO, GMP	Germany	Innovative excipients, stability
DHL Supply Chain	Logistics provider	-	Global	Cold chain, temperature-focused

8. Strategic Sourcing & Risk Mitigation
To mitigate supply disruptions, pharmaceutical firms employ diversification strategies, including dual sourcing, inventory buffer, and strategic stockpiles. Regulatory compliance and supplier audits form core components of risk management.

9. Future Trends in Supplier Landscape
Emerging trends include increased reliance on domestic API manufacturing to reduce geopolitical risks, adoption of digital supply chain management systems, and enhancements in quality control through automation.

Conclusion
The supply network for JAYTHARI incorporates a mix of global and regional suppliers spanning raw materials, manufacturing, and logistics. Maintaining a resilient, compliant, and quality-centric supply chain is key to consistent drug availability. Stakeholders must monitor geopolitical, regulatory, and technological developments to optimize sourcing strategies.

---

Key Takeaways

• JAYTHARI’s core suppliers include reputable API manufacturers like Galenica and Divis Labs, recognized for their compliance and quality standards.
• Reliable excipient suppliers such as BASF complement the supply chain, emphasizing stability and regulatory approval.
• Strategic diversification, rigorous quality assurance, and adherence to regulatory standards are vital to mitigate supply risks.
• Logistics providers specialized in cold chain support are crucial for ensuring drug stability during transit.
• Future supply chain resilience will increasingly depend on digital transparency, local manufacturing, and proactive risk management.

---

FAQs

1. Who are the primary API suppliers for JAYTHARI?
Key API suppliers include global manufacturers such as Galenica and Divis Labs, known for their high-quality standards and regulatory compliance.

2. How does the supply chain ensure the quality of raw materials used in JAYTHARI?
Suppliers undergo rigorous qualification processes, including GMP certifications, batch testing, and documentation such as Certificates of Analysis, ensuring compliance with pharmacopoeia standards.

3. What are the common challenges faced in sourcing for JAYTHARI?
Challenges include API shortages, geopolitical risks, regulatory hurdles, and maintaining high quality while controlling costs.

4. How does logistics influence the supply of JAYTHARI?
Logistics providers specializing in cold chain management, like DHL Supply Chain, are essential for maintaining drug stability during transit.

5. What trends are shaping the future supply chain of pharmaceuticals like JAYTHARI?
Increasing localization of API manufacturing, digital supply chain transparency, and enhanced risk mitigation strategies define future trends.

---

Sources:
[1] Pharmaceutical Manufacturing and Supply Chain Insights, IQVIA Reports, 2022.
[2] API Market Analysis, Global Industry Analysts, 2023.
[3] Good Manufacturing Practices and Regulatory Standards, U.S. FDA, 2023.